Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
AstraZeneca
Chinese Patent Office
Argus Health
Boehringer Ingelheim
Federal Trade Commission
Chubb
Cipla
Queensland Health
Express Scripts

Generated: August 21, 2017

DrugPatentWatch Database Preview

Loperamide hydrochloride; simethicone - Generic Drug Details

« Back to Dashboard

What are the generic sources for loperamide hydrochloride; simethicone and what is the scope of loperamide hydrochloride; simethicone patent protection?

Loperamide hydrochloride; simethicone
is the generic ingredient in two branded drugs marketed by Sun Pharm Inds Ltd, J And J Consumer Inc, and Perrigo, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Loperamide hydrochloride; simethicone has twenty patent family members in seventeen countries.

There are eleven drug master file entries for loperamide hydrochloride; simethicone. One supplier is listed for this compound.

Summary for Generic Name: loperamide hydrochloride; simethicone

Tradenames:2
Patents:1
Applicants:3
NDAs:4
Drug Master File Entries: see list11
Suppliers / Packagers: see list1
Clinical Trials: see list2,333
Drug Prices:see low prices
DailyMed Link:loperamide hydrochloride; simethicone at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
loperamide hydrochloride; simethicone
TABLET;ORAL077500-001Sep 6, 2006OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo
LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
loperamide hydrochloride; simethicone
TABLET, CHEWABLE;ORAL076029-001Aug 30, 2002OTCNoYes► Subscribe► Subscribe► Subscribe
J And J Consumer Inc
IMODIUM MULTI-SYMPTOM RELIEF
loperamide hydrochloride; simethicone
TABLET;ORAL021140-001Nov 30, 2000OTCYesYes► Subscribe► SubscribeY ► Subscribe
J And J Consumer Inc
IMODIUM MULTI-SYMPTOM RELIEF
loperamide hydrochloride; simethicone
TABLET, CHEWABLE;ORAL020606-001Jun 26, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: loperamide hydrochloride; simethicone

International Patent Family for Ingredient: loperamide hydrochloride; simethicone

Country Document Number Estimated Expiration
Denmark0891776► Subscribe
JapanH1192387► Subscribe
Austria259236► Subscribe
Hungary9801615► Subscribe
China1267106► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: LOPERAMIDE HYDROCHLORIDE; SIMETHICONE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/013United Kingdom► SubscribePRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Novartis
Johnson and Johnson
US Department of Justice
Colorcon
Julphar
Citi
McKesson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot